A schematic diagram illustrating the innervation pattern of layer II/III pyramidal neurons in S1 (A). Confocal images of layer II/III pyramidal neurons in S1 labeled by targeted IUE at E15.5 with plasmids encoding eGFP (B-N). Images were taken at time points ranging from P0 to P14 in the areas innervated by S1 layer II/III pyramidal neurons.
Brain sections were counter stained with either with DAPI (red, B), or Cux1 (red) and CTIP2 (blue) to demarcate cortical layers II-IV and V, respectively (C-N). At P0 layer II/ III pyramidal neurons are completing migration as their axons project towards the corpus callosum (composite panoramic image B, white arrows). In the ipsilateral S1 cortex (C-F), collateral axons begin to form at P3 (C) and a clear axonal plexus may be observed in layer V at P10 (E). The primary axon may be observed entering the contralateral S1 cortex at P3 (G). By P5, axons reach the most superficial layers of the cerebral cortex (H). Terminal arbors of the primary axon are present at P10 (I), and the laminar specific innervation of layers II/III and layer V in the contralateral S1 cortex may be observed by P14 (J). In the ipsilateral M1 cortex, axons from layer II/III S1 pyramidal neurons are present by P5 (K) and laminar specific innervation is observed at P14 (L).
Similarly, axons from layer II/III S1 pyramidal neurons we observed in the ipsilateral S2 cortex at P5 (M) and laminar specific innervation is present at P14 (N). Plasmids encoding tdTomato and plasmids encoding either IRES-eGFP (control) or Kir2.1-IRES-eGFP were introduced into layer II/III pyramidal neurons by IUE at E15.5.
Confocal images of 250µm fixed coronal sections were used to assess laminar-specific 5 innervation of layer II/III pyramidal neurons at P5 (A,B) and P14 (D,E) by tdTomato fluorescence (green). Brain sections were counterstained with DAPI (red) to determine cortical laminae locations (A,B,D,E). At P5 (C) and at P14 (F) a significant increase in the innervation of layer V, as compared to layers IV and VI, was found within both control and Kir2.1-expressing animals. By two-way ANOVA no significant difference was found between of control and Kir2.1-expressing animals at P5, however a significant difference was found in the ratios of innervation between control and Kir2.1-expressing animals at P14. * Indicates a P value < 0.05. ** indicates a P value < 0.01. *** indicates a P value < 0.001. NS indicates no significance. Error bars denote standard deviation. Layer II/III pyramidal neurons from S1 were labeled by IUE of plasmids encoding eGFP (black) at E15.5. A tile scan image consisting of 11 x 8 fields with a 10x objective was taken of a P4 400µm organotypic brain section every hour for 24 hours. Axons from S1 layer II/III pyramidal neurons can be observed navigating to their appropriate targets in the contralateral S1, ipsilateral M1, and ipsilateral S2. Layer II/III pyramidal neurons from S1 were sparsely labeled by IUE of plasmids encoding eGFP (black) at E15.5. A tile scan image was obtained with a 20x objective every hour for 16hrs from a P2.5 400µm organotypic brain section. Short collateral axon branches can be observed emerging and retracting all along the primary axon.
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Supplemental Experimental Procedures
Plasmids. For general labeling of neurons with eGFP ( Figures 1 and S1 ) or tdTomato ( Figures 5 and S4 ), a pCAG-eGFP plasmid at a concentration of 2µg/µl or a pEF1-tdTomato plasmid at a concentration of 1µg/µl were used. The tdTomato plasmid was used at lower concentrations since tdTomato is inherently brighter than eGFP. For sparse labeling with eGFP ( Figures 1, 2 , 3, and 4; Movies S1 and S3), plasmids encoding Cre-dependent eGFP (pCAG-LSL-eGFP at a concentration of 2µg/µl) and Cre (pCAG-Cre at concentrations ranging between 1-10ng/ul) were co-electroporated (the lower the concentration of the Cre plasmid, the more sparse the labeling with eGFP becomes). To visualize multiple cells simultaneously ( Figure S2 and Movie S2), we generated and electroporated a recombination-assisted neural delineation plasmid, pCAG-Randbow, along with the pCAG-Cre plasmid at concentrations of 2µg/µl and 10ng/µl, respectively. pCAG-Randbow was created by optimizing the pCx-Cytobow (a kind gift from Alain Chédotal). This optimization involved inserting a polyA sequence upstream of tdTomato and a loxN sequence downstream of tdTomato to make the expression of tdTomato conditional upon Cre-mediated recombination. We also replaced the Cerulean and Venus fluorophores from pCx-Cytobow with tagBFP and eGFP fluorophores, whose excitation and emission spectra align better with our imaging system. To label the f-actin cytoskeleton (Figure 6 ), we electroporated embryos with the pCAG-UtrCh-mRFP plasmid at a concentration of 250ng/µl. In experiments involving the manipulation of intrinsic neural activity, we introduced either a pCAG-IRES-eGFP plasmid as a control or a pCAG-Kir2.1-IRES-eGFP at concentrations of 1µg/µl.
Antibodies. Primary antibodies were diluted in permeabilization buffer as follows: innervation experiments, areas of equal size were used to measure the fluorescent intensity within each layer ( Figure S4 ). In the Kir2.1 experiments innervation experiments 12 control animals and 12 Kir2.1 expressing animals were quantified (7 animals for each group at P5 and 5 animals for each group at P14). For the corpus callosum lesion and thalamocortical axon lesion experiments, areas of equal size were used to measure the fluorescent intensity within each layer ( Figure 5 ). For the corpus callosum lesion experiments, 3 control (non-lesioned) animals and 4 lesioned animals were quantified; for the thalamocortical axon lesion experiments 4 control and 4 lesioned animals were quantified.
